-
Federal
U.S. Chronic Disease Indicators
U.S. Department of Health & Human Services —
CDC's Division of Population Health provides a cross-cutting set of 115 indicators developed by consensus among CDC, the Council of State and Territorial... -
Federal
Drugs@FDA Database
U.S. Department of Health & Human Services —
Information about FDA-approved brand name and generic prescription and over-the-counter human drugs and biological therapeutic products. Drugs@FDA includes most of... -
Federal
LactMed (Drugs and Lactation Database)
U.S. Department of Health & Human Services —
LactMed (Drugs and Lactation Database) contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. It includes information on the... -
Federal
Nutrition, Physical Activity, and Obesity - Behavioral Risk Factor Surveillance System
U.S. Department of Health & Human Services —
This dataset includes data on adult's diet, physical activity, and weight status from Behavioral Risk Factor Surveillance System. This data is used for DNPAO's Data,... -
Federal
Drug overdose death rates, by drug type, sex, age, race, and Hispanic origin: United States
U.S. Department of Health & Human Services —
Data on drug overdose death rates, by drug type and selected population characteristics. Please refer to the PDF or Excel version of this table in the HUS 2019 Data... -
Federal
NCHS - Leading Causes of Death: United States
U.S. Department of Health & Human Services —
This dataset presents the age-adjusted death rates for the 10 leading causes of death in the United States beginning in 1999. Data are based on information from all... -
Federal
Provider of Services File - Hospital & Non-Hospital Facilities
U.S. Department of Health & Human Services —
Please be advised that as of Q4 2023 there is a new Provider of Service file (POS) that contains the provider and certification details for Home Health Agencies... -
Federal
Orange Book
U.S. Department of Health & Human Services —
The Approved Drug Products with Therapeutic Equivalence (Orange Book or OB) is a list of drugs approved under Section 505 of the Federal Food, Drug and Cosmetic Act... -
Federal
Medicare Part B Spending by Drug
U.S. Department of Health & Human Services —
The Medicare Part B by Drug dataset presents information on spending for drugs administered in doctors’ offices and other outpatient settings by physicians and other... -
Federal
Heart Disease Mortality Data Among US Adults (35+) by State/Territory and County – 2019-2021
U.S. Department of Health & Human Services —
2019 to 2021, 3-year average. Rates are age-standardized. County rates are spatially smoothed. The data can be viewed by sex and race/ethnicity. Data source: National... -
Federal
Warning Letters
U.S. Department of Health & Human Services —
An index of FDA warning letters issued to companies operating in the United States. -
Federal
State TANF Data
U.S. Department of Health & Human Services —
States receive block grants to design and operate programs that accomplish the purposes of the TANF program (Temporary Assistance for Needy Families). The Office of... -
Federal
Find Shortage Areas: HPSA & MUA/P by Address
U.S. Department of Health & Human Services —
The Find Shortage Areas: Health Professional Shortage Area (HPSA) and Medically Underserved Area/Population (MUA/P) by Address tool helps you determine if a specific... -
Federal
Monthly Rates of Laboratory-Confirmed COVID-19 Hospitalizations from the COVID-NET Surveillance System
U.S. Department of Health & Human Services —
The Coronavirus Disease 2019 (COVID-19) Hospitalization Surveillance Network (COVID-NET) a network that conducts active, population-based surveillance for laboratory-... -
Federal
Death rates for suicide, by sex, race, Hispanic origin, and age: United States
U.S. Department of Health & Human Services —
Data on death rates for suicide, by selected population characteristics. Please refer to the PDF or Excel version of this table in the HUS 2019 Data Finder... -
Federal
Premarket Notifications (510(k)s)
U.S. Department of Health & Human Services —
Medical device manufacturers are required to submit a premarket notification or 510(k) if they intend to introduce a device into commercial distribution for the first...